Richard Phillips, MD, PhD

Funded by the Stuart Scott Memorial Cancer Research Fund

Adult midline gliomas are aggressive, unresectable tumors for which no curative treatments exist. These tumors are caused by faulty ‘epigenetics’ i.e. problems in the way cells switch certain genes ‘on’ or ‘off’. Our research is studying a protein complex called PRC1, which we have found these tumors use to keep certain genes switched off to promote growth. We aim to understand how PRC1 functions so that we can devise novel ways to target this pathway and develop new treatments for this disease.

Location: Abramson Cancer Center - Philadelphia
Proposal: Targeting chromatin in adult midline glioma
Mailing List Mailing List
Close Mailing List